
    
      This Study shows that topical treatment with Recombinant Nerve Growth Factor (rhNGF) improved
      corneal sensitivity and increased sub-basal nerves density, promoting corneal healing of
      persistent epithelial defects and corneal ulcers in patients with stage 2 and 3 NK
    
  